권호기사보기
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
결과 내 검색
동의어 포함
Objectives : The aim of this study were to assess a) the prevalence of metabolic syndrome in outpatients with schizophrenia or schizoaffective disorder, b) the comparison of characteristics of patients with or without the metabolic syndrome, c) the sensitivity, specificity and positive predictive values of individual criteria for metabolic syndrome.
Methods : This study assessed the prevalence of the metabolic syndrome among 128 schizophrenia or schizoaffective disorder patients using the National Cholesterol Education Program-Adult Treatment Panel III.
Results : Of patients, 54.7% (M : 49.3%, F : 61.4%) had metabolic syndrome. The metabolic syndrome was associated with medical history of diabetes, hypertension and dyslipidemia. Presence of abdominal obesity was most sensitive (97.1%), while raised fasting glucose was most specific (89.7%). Combining abdominal obesity/raised triglycerides and abdominal obesity/low HDL cholesterol had 100% sensitivity.
Conclusion : The metabolic syndrome is highly prevalent among outpatients with schizophrenia or schizoaffective disorder. This study suggests that the measurement of abdominal obesity is a simple test to identify individuals at high risk for metabolic syndrome.| 기사명 | 저자명 | 페이지 | 원문 | 목차 |
|---|---|---|---|---|
| Schizoaffective disorder | Andreas Marneros | pp.5-12 |
|
|
| 조현정동장애와 정신증적 양상을 동반한 기분장애를 어떻게 구별할 수 있나? | 박철현, 박태원, 양종철, 오근영, 김형태, 은홍배, 황광표, 정영철 | pp.13-19 |
|
|
| 만성 조현병 환자에서 12주 체중관리 프로그램이 삶의 질에 미치는 영향 | 김재진, 제영묘, 이대수, 최진혁, 박숙현 | pp.20-26 |
|
|
| 조현병에서 긍정 정서가 인지적 갈등 해결에 미치는 영향과 사회적 무쾌감증과의 관계 | 박재섭, 전지원, 박일호, 김어수, 김재진 | pp.27-33 |
|
|
| Tryptophan Hydroxylase 2 유전자다형성과 항정신병약물로 유발된 지연성운동장애의 연관성 | 이종훈, 강승걸, 박영민, 이헌정, 김석주, 김린 | pp.34-38 |
|
|
| 조현병, 조현정동장애 외래 환자들의 대사증후군 유병률 | 이화영, 최정은 | pp.39-45 |
|
|
| Blonanserin 투여 중 조증을 보인 28세 조현병 환자의 증례 | 박소영, 김용구, 이종하 | pp.46-49 |
|
| 번호 | 참고문헌 | 국회도서관 소장유무 |
|---|---|---|
| 1 | The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. ![]() |
미소장 |
| 2 | Definition of multiple ICA512/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes. ![]() |
미소장 |
| 3 | Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). ![]() |
미소장 |
| 4 | The metabolic syndrome—a new worldwide definition ![]() |
미소장 |
| 5 | Excess mortality of schizophrenia ![]() |
미소장 |
| 6 | Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. ![]() |
미소장 |
| 7 | High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia. ![]() |
미소장 |
| 8 | Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome. ![]() |
미소장 |
| 9 | The association of medical comorbidity in schizophrenia with poor physical and mental health. ![]() |
미소장 |
| 10 | Body weight and self-esteem in patients with schizophrenia evaluated with B-WISE® ![]() |
미소장 |
| 11 | Obesity as a risk factor for antipsychotic noncompliance. ![]() |
미소장 |
| 12 | Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005;19 Suppl 1:1-93. | 미소장 |
| 13 | Wirshing DA. Schizophrenia and obesity: impact of antipsychotic medications. J Clin Psychiatry 2004;65 Suppl 18:13-26. | 미소장 |
| 14 | Newcomer JW. Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry 2007;68 Suppl 4:8-13. | 미소장 |
| 15 | FAMILY HISTORY OF TYPE 2 DIABETES IN SCHIZOPHRENIC PATIENTS ![]() |
미소장 |
| 16 | Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. ![]() |
미소장 |
| 17 | Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia. ![]() |
미소장 |
| 18 | Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial ![]() |
미소장 |
| 19 | Scheen AJ, De Hert M. [Drug-induced diabetes mellitus: the exemple of atypical antipsychotics]. Rev Med Liege 2005;60:455-460. | 미소장 |
| 20 | Abnormal glucose metabolism in patients treated with antipsychotics. ![]() |
미소장 |
| 21 | Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. ![]() |
미소장 |
| 22 | Clinical Correlates of Metabolic Syndrome in Patients with Chronic Schizophrenia | 소장 |
| 23 | Jeong JT, Yoon BH, Kim TU, Sea YH, Park SH, Jeong KY, et al. Prevalence of Metabolic Syndrome in Chronic Schizophrenic Inpatients. Korean J Schizophr Res 2009;12:83-89. | 미소장 |
| 24 | The Prevalence of Metabolic Syndrome in Inpatients with Schizophrenia | 소장 |
| 25 | Lee NY, Kim SK, Kim SH, Kang U, Kim YS, Ahn YM. Metabolic syndrome in patients with Schizophrenia and Bipolar disorder: comparision with general population. Abstracted presented at the Korea Neuropsychiatric Association Annual Meeting Seoul;2008. | 미소장 |
| 26 | Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia. ![]() |
미소장 |
| 27 | Association AP. Diagnostic and Statistical Manual of Mental Disorders( DSM-IV-TR). 4th evidence-based text revision ed. Washington, DC: American Psychiatric Association;2000. | 미소장 |
| 28 | Hales RE, Yudofsky SC, Gabbard GO. Text book of Psychiatry. 5 ed. American psychiatric publishing, Inc.;2008. | 미소장 |
| 29 | Performance of the CardioChek™ PA and Cholestech LDX® point-of-care analysers compared to clinical diagnostic laboratory methods for the measurement of lipids ![]() |
미소장 |
| 30 | World health organization. The Asia-Pacific perspective: redefining obesity and its treatment. Februrary 2000. Health Communications, Australia PTY Ltd. | 미소장 |
| 31 | Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M. Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders--A Systematic Review and Meta-Analysis. Schizophr Bull 2011;Dec 29. [Epub ahead of print]. | 미소장 |
| 32 | Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications. ![]() |
미소장 |
| 33 | Koponen HJ, Hakko HH, Saari KM, Lindeman SM, Karvonen KM, Isohanni MK, et al. The prevalence and predictive value of individual criteria for metabolic syndrome in schizophrenia: a Northern Finland 1966 Birth Cohort Study. World J Biol Psychiatry 2010;11: 262-267. | 미소장 |
| 34 | Kagal UA, Torgal SS, Patil NM, Malleshappa A. Prevalence of the Metabolic Syndrome in Schizophrenic Patients Receiving Second- Generation Antipsychotic Agents--A Cross-Sectional Study. J Pharm Pract 2012;May 2. [Epub ahead of print]. | 미소장 |
| 35 | Metabolic syndrome and psychiatrists' choice of follow-up interventions in patients treated with atypical antipsychotics in Denmark and Sweden. ![]() |
미소장 |
| 36 | Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. ![]() |
미소장 |
| 37 | Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort ![]() |
미소장 |
| 38 | Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics. ![]() |
미소장 |
| 39 | Metabolic syndrome with the atypical antipsychotics. ![]() |
미소장 |
| 40 | Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. ![]() |
미소장 |
| 41 | Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics. ![]() |
미소장 |
| 42 | Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study. ![]() |
미소장 |
| 43 | A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: Findings from the CLAMORS study ![]() |
미소장 |
| 44 | The incidence of metabolic syndrome and its reversal in a cohort of schizophrenic patients followed for one year ![]() |
미소장 |
| 45 | Metabolic syndrome in female patients with schizophrenia treated with second generation antipsychotics: a 3-month follow-up. ![]() |
미소장 |
*표시는 필수 입력사항입니다.
| 전화번호 |
|---|
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
| 번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
|---|
도서위치안내: 정기간행물실(524호) / 서가번호: 국내03
2021년 이전 정기간행물은 온라인 신청(원문 구축 자료는 원문 이용)
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.